Abstract
Nanotechnology is an emergent field with numerous applications in drug delivery, clinical medicine, nutriceuticals as well as in other fields also. In this techno, Solid lipid nanoparticles (SLN) is a part which consist solid colloidal particles ranging in size from 1 to 1000 nm and act as “magic bullet” when coupled with ligands/targeting ligands. SLN consisting of a solid-lipid promising advance delivery of lipophilic drugs and also used as an alternate for conventional carriers such as micro-emulsions, liposomes and nanoparticles based on natural/synthetic polymers. They are formulated from synthetic/natural lipids and optimize the drug delivery to provide a protection to sensitive drugs and obtain better/improve bioavailability with less toxicity (as compared to polymeric NPs) due to its biodegradable/bioacceptable nature. Moreover, Surface Modified SLNs is a new promising approach for protein loading and antigen delivery system.
Keywords: Nanotechnology, solid lipid nanoparticles (SLN), drug delivery, toxicity.
Nanoscience & Nanotechnology-Asia
Title:Solid Lipid Nanoparticles: An Innovative Nano-Vehicles for Drug Delivery
Volume: 4 Issue: 1
Author(s): Hema Chaudhary, Samita, Nitika Puri and Vikash Kumar
Affiliation:
Keywords: Nanotechnology, solid lipid nanoparticles (SLN), drug delivery, toxicity.
Abstract: Nanotechnology is an emergent field with numerous applications in drug delivery, clinical medicine, nutriceuticals as well as in other fields also. In this techno, Solid lipid nanoparticles (SLN) is a part which consist solid colloidal particles ranging in size from 1 to 1000 nm and act as “magic bullet” when coupled with ligands/targeting ligands. SLN consisting of a solid-lipid promising advance delivery of lipophilic drugs and also used as an alternate for conventional carriers such as micro-emulsions, liposomes and nanoparticles based on natural/synthetic polymers. They are formulated from synthetic/natural lipids and optimize the drug delivery to provide a protection to sensitive drugs and obtain better/improve bioavailability with less toxicity (as compared to polymeric NPs) due to its biodegradable/bioacceptable nature. Moreover, Surface Modified SLNs is a new promising approach for protein loading and antigen delivery system.
Export Options
About this article
Cite this article as:
Chaudhary Hema, Samita , Puri Nitika and Kumar Vikash, Solid Lipid Nanoparticles: An Innovative Nano-Vehicles for Drug Delivery, Nanoscience & Nanotechnology-Asia 2014; 4 (1) . https://dx.doi.org/10.2174/22106812113036660003
DOI https://dx.doi.org/10.2174/22106812113036660003 |
Print ISSN 2210-6812 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-6820 |
Call for Papers in Thematic Issues
Nanotechnology for Energy Harness and Material Development
The energy industry is one of the many that is being revolutionized by nanotechnology. There is great hope for the commercialization of these breakthroughs since they have the potential to make energy production safer, far more sustainable, greater efficient, and less expensive. Nanotechnology is being studied for its potential to ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
MiR 221/222 as New Players in Tamoxifen Resistance
Current Pharmaceutical Design Docetaxel-loaded Bovine Serum Albumin Nanoparticles Conjugated Docosahexaenoic Acid for Inhibiting Lung Cancer Metastasis to Bone
Anti-Cancer Agents in Medicinal Chemistry Epidermal Growth Factor Receptor (EGFR) Targeted Therapies in Non- Small Cell Lung Cancer (NSCLC)
Reviews on Recent Clinical Trials Meet Our Associate Editor
Anti-Cancer Agents in Medicinal Chemistry Spectrum of Radiopharmaceuticals in Nuclear Oncology
Current Cancer Drug Targets A Review on Recent Developments in Positron Emission Tomography Technology
Recent Patents on Medical Imaging Prodrug Design of Phenolic Drugs
Current Pharmaceutical Design Editorial [Hot Topic: Overview of Antiangiogenic Therapies in Hematological Malignancies (Guest Editor: D. Ribatti)]
Current Cancer Drug Targets Peroxisome Proliferator-Activated Receptors: Role of Isoform Gamma in the Antineoplastic Effect of Iodine in Mammary Cancer
Current Cancer Drug Targets Homology Modeling of MDR1 Gene MDR1_ENTHI of <i>E. histolytica</i> & its Molecular Docking with Anti-Entamoeba Histolytica Agents
Current Topics in Medicinal Chemistry Exosomes: Structure, Biogenesis, Types and Application in Diagnosis and Gene and Drug Delivery
Current Gene Therapy Basic Mechanisms Involved in the Anti-Cancer Effects of Melatonin
Current Medicinal Chemistry Regulation of Protective and Pathogenic Th17 Responses
Current Immunology Reviews (Discontinued) Natural Products Based Anticancer Agents
Mini-Reviews in Organic Chemistry 6,7-Dimethoxyquinazolines as Potential Cytotoxic Agents: Synthesis and in vitro Activity
Letters in Drug Design & Discovery Folate Nutrigenetics: A Convergence of Dietary Folate Metabolism, Folic Acid Supplementation, and Folate Antagonist Pharmacogenetics
Drug Metabolism Letters Aliphatic Nucleophilic Radiofluorination
Current Radiopharmaceuticals Meet Our Executive Editor
Current Traditional Medicine Bio-analytical Identification of Key Genes that Could Contribute to the Progression and Metastasis of Osteosarcoma
Current Bioinformatics Anti-VEGF Anticancer Drugs: Mind the Hypertension
Recent Advances in Cardiovascular Drug Discovery (Discontinued)